Home > Financial Ratios > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 24.0847.24-21.1914.7853.68

What is the latest EBIT Growth ratio of TORRENT PHARMACEUTICALS ?

The latest EBIT Growth ratio of TORRENT PHARMACEUTICALS is 24.08 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar202424.08
Mar202347.24
Mar2022-21.19
Mar202114.78
Mar202053.68

How is EBIT Growth of TORRENT PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2024 24.08
-49.03
Mar2023 47.24
Positive
Mar2022 -21.19
Negative
Mar2021 14.78
-72.47
Mar2020 53.68 -

Other Financial Ratios of TORRENT PHARMACEUTICALS


Compare EBIT Growth ratio of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹116,215.0 Cr 2.2% 10.6% 61.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,920.0 Cr -0.1% 1.7% 45.7% Stock Analytics
DIVIS LABORATORIES ₹155,160.0 Cr -0.1% -2.2% 56.9% Stock Analytics
CIPLA ₹118,917.0 Cr 1.7% 0.5% 23.7% Stock Analytics
DR REDDYS LABORATORIES ₹112,017.0 Cr 5.7% 12.4% 18.5% Stock Analytics
ZYDUS LIFESCIENCES ₹97,997.1 Cr -1.4% 3.1% 44.8% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

2.2%

10.6%

61.7%

SENSEX

-5%

0.6%

9.2%


You may also like the below Video Courses